Related Experiment Video
Updated: Feb 17, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer
Wei Zhao1,2, Qingyuan Zhu1, Peng Tan1,3
1Center for Inflammation and Epigenetics, Houston Methodist Research Institute, Houston, TX, USA.
Abstract:
Mutations in tumors can create a state of increased cellular plasticity that promotes resistance to treatment. Thus, there is an urgent need to develop novel strategies for identifying key factors that regulate cellular plasticity in order to combat resistance to chemotherapy and radiation treatment. Here we report that prostate epithelial cell reprogramming could be exploited to identify key factors required for promoting prostate cancer tumorigenesis and cellular plasticity. Deletion of phosphatase and tensin homolog (Pten) and transforming growth factor-beta receptor type 2 (Tgfbr2) may increase prostate epithelial cell reprogramming efficiency in vitro and cause rapid tumor development and early mortality in vivo. Tgfbr2 ablation abolished TGF-β signaling but increased the bone morphogenetic protein (BMP) signaling pathway through the negative regulator Tmeff1. Furthermore, increased BMP signaling promotes expression of the tumor marker genes ID1, Oct4, Nanog, and Sox2; ID1/STAT3/NANOG expression was inversely correlated with patient survival. Thus, our findings provide information about the molecular mechanisms by which BMP signaling pathways render stemness capacity to prostate tumor cells.
Insights
Targeting cellular plasticity in prostate cancer is crucial for overcoming treatment resistance. This study identifies key factors, including bone morphogenetic protein (BMP) signaling, that drive prostate cancer stemness and poor patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor mutations can induce cellular plasticity, leading to treatment resistance.
- Novel strategies are needed to identify factors regulating cellular plasticity and combat chemoresistance.
Purpose of the Study:
- To explore prostate epithelial cell reprogramming for identifying key factors in prostate cancer tumorigenesis and plasticity.
- To investigate the roles of phosphatase and tensin homolog (Pten) and transforming growth factor-beta receptor type 2 (Tgfbr2) in prostate cancer progression.
Main Methods:
- Utilized in vitro cell reprogramming and in vivo studies involving Pten and Tgfbr2 deletion in prostate epithelial cells.
- Analyzed the impact of Tgfbr2 ablation on TGF-β and bone morphogenetic protein (BMP) signaling pathways.
- Assessed the expression of tumor marker genes (ID1, Oct4, Nanog, Sox2) and their correlation with patient survival.
Main Results:
- Deletion of Pten and Tgfbr2 enhanced prostate epithelial cell reprogramming efficiency and promoted rapid tumor development.
- Tgfbr2 ablation suppressed TGF-β signaling while upregulating BMP signaling via Tmeff1.
- Increased BMP signaling correlated with elevated expression of ID1, Oct4, Nanog, and Sox2, which were inversely linked to patient survival.
Conclusions:
- Prostate epithelial cell reprogramming is a viable strategy to uncover factors driving cancer plasticity and tumorigenesis.
- BMP signaling pathways play a critical role in conferring stemness to prostate tumor cells.
- The ID1/STAT3/NANOG axis represents a potential therapeutic target for improving patient outcomes in prostate cancer.
More Related Videos
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules